Propanc Biopharma Plans to Purchase $100 Million Worth of Ethereum in the Next 12 Months

BlockBeats News, September 2nd, US-listed biopharmaceutical company Propanc Biopharma (PPCB) announced plans to buy $100 million worth of Ethereum in the next 12 months. Propanc Biopharma stated that this move will enhance its overall corporate strategy in various areas such as cryptocurrency investment, drug development, and asset acquisition.